Evaluating Capacity/Collaboration Building Efforts

Not as Easy as You Think!

The Gestational Diabetes Collaborative

National Association of Chronic Disease DirectorsProgram Integration Teleconference

September 12, 2011

National Collaborators CDC Division of Diabetes Translation CDC Division of Reproductive Health Association of Maternal and Child

Health Programs (AMCHP) National Association of Chronic

Disease Directors (NACDD) NACDD Women’s Health and Diabetes

Councils

What Is the Goal of This Project?

To foster integration (collaboration) of MCH and chronic disease programs in the development of diabetes prevention

initiatives

Objectives of this Project

Discover connections between maternal health and chronic disease prevention across the lifespan, especially for women of child-bearing age (15-44).

Articulate lessons learned from maternal and child health (MCH) and chronic disease initiatives that focus on diabetes prevention among women of child-bearing age.

Understand the maternal and infant complications associated with GDM and particularly, the increased risk of developing Type 2 diabetes among women with a history of GDM).

Objectives continued Share information about existing state data sources that can

monitor:◦prevalence of GDM◦prevalence of type 2 diabetes among women ages 15-44

years◦risk factors for GDM and type 2 diabetes such as obesity, inactivity, family history of diabetes, and previous birth of an infant >4000 grams.

Develop a state action plan to prevent or delay the development of Type II diabetes among women who have a history of GDM.

Identify and prioritize at least three possible strategies for MCH and chronic disease program collaboration to address critical issues in gestational diabetes data collection, diagnosis, treatment and follow-up

Objectives continued Engage in teambuilding to develop the plan for

action

Identify and address factors that promote or hinder MCH and chronic disease collaborations

List potential partners (internal and external) to assist in collaboration

Participate in a capacity assessment survey at baseline and 12 months later

Methods 1 ½ day workshop on collaboration Baseline and follow-up assessments

after 12 months Zoomerang assessments completed

independently by MCH and Chronic Disease Directors

States: Missouri, Ohio, West Virginia

Assessment Design Three Sections

I. MCH and CD Collaboration

II. GDM Competencies

III. Capacity for reducing Type 2 Diabetes among women with hx of GDM

Likert ScaleAssigned points to Scale:

1 = Strongly disagree2 = Disagree3 = Neutral4 = Agree5 = Strongly agree

I: Networking/Cooperation Participate on committees together Have constructive work relationships Are committed to the GDM

collaboration Seek opportunities to collaborate Support each others’ program’s efforts Keep appointments with one another

I. Coordination/Resource Sharing

Share data and information of mutual interest

Proactively coordinate on assignments of common interest

Regularly meet about programming

I. Policy Development, Planning, and

Decision-Making Invite participation of one another when developing

messaging, marketing, or packaging of promotional materials

Share accountability and credit for joint initiatives’ successes

Jointly plan analyses and publications Share resources to expand services Jointly develop funding applications Jointly develop policy around women’s health issues Make decisions together to further enhance women’s

health issues

II. Knowledge/Ability Association between GDM and development of

Type 2 diabetes Key overlapping chronic disease and MCH

issues related to GDM and diabetes prevention Evidence-based approaches to GDM

management, prevention and control Current scientific evidence for GDM/diabetes

prevention programs and practices GDM/diabetes prevention initiatives for

different populations

II. Data Identify appropriate data sources relevant to

GDM/diabetes prevention initiatives Use data to identify and monitor GDM and diabetes

burden, trends, and outcomes among women Use data to develop recommendations for changes

in policy, programs, data collection, and practice. Use data to develop and prioritize intervention

strategies for GDM/diabetes prevention initiatives Use MCH and Diabetes program evaluation findings

to improve GDM/diabetes prevention initiatives

III. Funding

Dedicated funding for GDM initiatives Funding for staff training related to

GDM initiatives Budget for medical supplies or

equipment related to GDM initiatives Budget for promoting GDM initiatives

III. Staffing Dedicated staff time for GDM program

integration efforts Commitment to GDM program integration efforts GDM programmatic knowledge, training, and

skills Adequate time to monitor program activities Ability to effectively build support with

management Access to program evaluation expert

consultation on GDM initiatives

III. Effective Leadership Leadership support for MCH and CD collaboration

and integration in general Leadership support for developing or enhancing

current GDM activities to prevent Type 2 Diabetes Adequate oversight/management of GDM integrated

efforts Mentoring/technical assistance for GDM integrated

efforts GDM Program integration is a priority for leadership Has a GDM master plan and effective communication

of that vision

III. Internal Administrative Systems

Integrated data collection and surveillance systems Compatible administrative system across their

programs Compatible information technology and computer

systems across programs Coordinated management systems across

programs Communication networks and tools facilitate

information sharing

Preliminary Results Overall, there was increased capacity

and collaboration for GDM work between baseline and at the 12-month follow-up

Next Steps Due to staff changes in one state, the

assessments were completed by different people at baseline and follow-up, necessitating interviews with each state team member for validation of results

After validation and further analysis, results will be published and available

Contact InformationJoan Ware, Consultant

National Assoc. of Chronic Disease Directors

801-277-2353

ware@chronicdisease.org